Davenport & Co’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,633
| Closed | -$13K | – | 1061 |
|
|
2022
Q1 | $13K | Sell |
2,633
-1,767
| -40% | -$8.72K | ﹤0.01% | 1037 |
|
|
2021
Q4 | $25K | Sell |
4,400
-20,317
| -82% | -$115K | ﹤0.01% | 1042 |
|
|
2021
Q3 | $274K | Sell |
24,717
-2,056
| -8% | -$22.8K | ﹤0.01% | 891 |
|
|
2021
Q2 | $454K | Buy |
26,773
+153
| +0.6% | +$2.59K | ﹤0.01% | 675 |
|
|
2021
Q1 | $699K | Buy |
26,620
+6,933
| +35% | +$182K | 0.01% | 465 |
|
|
2020
Q4 | $712K | Buy |
19,687
+8,534
| +77% | +$309K | 0.01% | 438 |
|
|
2020
Q3 | $395K | Buy |
11,153
+7,106
| +176% | +$252K | ﹤0.01% | 515 |
|
|
2020
Q2 | $172K | Sell |
4,047
-1,250
| -24% | -$53.1K | ﹤0.01% | 661 |
|
|
2020
Q1 | $423K | Buy |
5,297
+2,957
| +126% | +$236K | 0.01% | 446 |
|
|
2019
Q4 | $217K | Buy |
+2,340
| New | +$217K | ﹤0.01% | 658 |
|